DAFNA Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

DAFNA Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$701K	Hold
2024 Q1	$727K	Sell
2023 Q4	$1.67M	Sell
2023 Q3	$1.05M	Hold
2023 Q2	$838K	Hold
2023 Q1	$710K	Hold
2022 Q4	$955K	Hold
2022 Q3	$1.71M	Buy